Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

This study has been completed.
Sponsor:
Information provided by:
FDA Office of Orphan Products Development
ClinicalTrials.gov Identifier:
NCT00004409
First received: October 18, 1999
Last updated: March 24, 2015
Last verified: May 2001
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given